|
1
|
Goguet-Surmenian E, Richard-Fiardo P,
Guillemot E, Benchetrit M, Gomez-Brouchet A, Buzzo P,
Karimdjee-Soilihi B, Alemanno P, Michiels JF, Schmid-Alliana A and
Schmid-Antomarchi H: CXCR7-mediated progression of osteo-sarcoma in
the lungs. Br J Cancer. 109:1579–1585. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Kansara M, Teng MW, Smyth MJ and Thomas
DM: Translational biology of osteosarcoma. Nat Rev Cancer.
14:722–735. 2014. View
Article : Google Scholar : PubMed/NCBI
|
|
3
|
Liu Y, Wu Y, Gu S, Sun Z, Rui Y, Wang J,
Lu Y, Li H, Xu K and Sheng P: Prognostic role of CD44 expression in
osteosarcoma: Evidence from six studies. Diagn Pathol. 9:1402014.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Chu J, Loughlin EA, Gaur NA, SenBanerjee
S, Jacob V, Monson C, Kent B, Oranu A, Ding Y, Ukomadu C and Sadler
KC: UHRF1 phosphorylation by cyclin A2/cyclin-dependent kinase 2 is
required for zebrafish embryogenesis. Mol Biol Cell. 23:59–70.
2012. View Article : Google Scholar :
|
|
5
|
Hopfner R, Mousli M, Jeltsch JM, Voulgaris
A, Lutz Y, Marin C, Bellocq JP, Oudet P and Bronner C: ICBP90, a
novel human CCAAT binding protein, involved in the regulation of
topoisomerase IIalpha expression. Cancer Res. 60:121–128.
2000.PubMed/NCBI
|
|
6
|
Jeanblanc M, Mousli M, Hopfner R, Bathami
K, Martinet N, Abbady AQ, Siffert JC, Mathieu E, Muller CD and
Bronner C: The retinoblastoma gene and its product are targeted by
ICBP90: A key mechanism in the G1/S transition during the cell
cycle. Oncogene. 24:7337–7345. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Benavente CA, Finkelstein D, Johnson DA,
Marine JC, Ashery-Padan R and Dyer MA: Chromatin remodelers HELLS
and UHRF1 mediate the epigenetic deregulation of genes that drive
retinoblastoma tumor progression. Oncotarget. 5:9594–9608. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Arima Y, Inoue Y, Shibata T, Hayashi H,
Nagano O, Saya H and Taya Y: Rb depletion results in deregulation
of E-cadherin and induction of cellular phenotypic changes that are
characteristic of the epithelial-to-mesenchymal transition. Cancer
Res. 68:5104–5112. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Arita K, Ariyoshi M, Tochio H, Nakamura Y
and Shirakawa M: Recognition of hemimethylated DNA by the SRA
protein UHRF1 by a base-flipping mechanism. Nature. 455:818–821.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Hashimoto H, Vertino PM and Cheng X:
Molecular coupling of DNA methylation and histone methylation.
Epigenomics. 2:657–669. 2010. View Article : Google Scholar
|
|
11
|
Rothbart SB, Krajewski K, Nady N, Tempel
W, Xue S, Badeaux AI, Barsyte-Lovejoy D, Martinez JY, Bedford MT,
Fuchs SM, et al: Association of UHRF1 with methylated H3K9 directs
the maintenance of DNA methylation. Nat Struct Mol Biol.
19:1155–1160. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Unoki M: Current and potential anticancer
drugs targeting members of the UHRF1 complex including epigenetic
modifiers. Recent Pat Anticancer Drug Discov. 6:116–130. 2011.
View Article : Google Scholar
|
|
13
|
Alhosin M, Sharif T, Mousli M,
Etienne-Selloum N, Fuhrmann G, Schini-Kerth VB and Bronner C:
Down-regulation of UHRF1, associated with re-expression of tumor
suppressor genes, is a common feature of natural compounds
exhibiting anti-cancer properties. J Exp Clin Cancer Res.
30:412011. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Li XL, Xu JH, Nie JH and Fan SJ: Exogenous
expression of UHRF1 promotes proliferation and metastasis of breast
cancer cells. Oncol Rep. 28:375–383. 2012.PubMed/NCBI
|
|
15
|
Zhang Y, Huang Z, Zhu Z, et al:
Upregulated UHRF1 promotes bladder cancer cell invasion by
epigenetic silencing of KiSS1. PLoS One. 9:e1042522014. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Babbio F, Pistore C, Curti L, et al: The
SRA protein UHRF1 promotes epigenetic crosstalks and is involved in
prostate cancer progression. Oncogene. 31:4878–4887. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Daskalos A, Oleksiewicz U, Filia A, et al:
UHRF1-mediated tumor suppressor gene inactivation in nonsmall cell
lung cancer. Cancer. 117:1027–1037. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Li XL, Meng QH and Fan SJ:
Adenovirus-mediated expression of UHRF1 reduces the
radiosensitivity of cervical cancer HeLa cells to
gamma-irradiation. Acta Pharmacol Sin. 30:458–466. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Mudbhary R, Hoshida Y, Chernyavskaya Y,
Jacob V, Villanueva A, Fiel MI, Chen X, Kojima K, Thung S, Bronson
RT, et al: UHRF1 overexpression drives DNA hypomethylation and
hepatocellular carcinoma. Cancer Cell. 25:196–209. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Zhuo H, Tang J, Lin Z, et al: The aberrant
expression of MEG3 regulated by UHRF1 predicts the prognosis of
hepatocellular carcinoma. Mol Carcinog. Jan 16–2015.Epub ahead of
print. View
Article : Google Scholar
|
|
21
|
Zhou L, Zhao X, Han Y, Lu Y, Shang Y, Liu
C, Li T, Jin Z, Fan D and Wu K: Regulation of UHRF1 by miR-146a/b
modulates gastric cancer invasion and metastasis. FASEB J.
27:4929–4939. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Manning AL, Yazinski SA, Nicolay B, Bryll
A, Zou L and Dyson NJ: Suppression of genome instability in
pRB-deficient cells by enhancement of chromosome cohesion. Mol
Cell. 53:993–1004. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Rosemann M, Gonzalez-Vasconcellos I, Domke
T, Kuosaite V, Schneider R, Kremer M, Favor J, Nathrath M and
Atkinson MJ: A Rb1 promoter variant with reduced activity
contributes to osteosarcoma susceptibility in irradiated mice. Mol
Cancer. 13:1822014. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Ory B, Blanchard F, Battaglia S, Gouin F,
Rédini F and Heymann D: Zoledronic acid activates the DNA S-phase
checkpoint and induces osteosarcoma cell death characterized by
apoptosis-inducing factor and endonuclease-G translocation
independently of p53 and retinoblastoma status. Mol Pharmacol.
71:333–343. 2007. View Article : Google Scholar
|
|
25
|
Lau MT, Klausen C and Leung PC: E-cadherin
inhibits tumor cell growth by suppressing PI3K/Akt signaling via
β-catenin-Egr1-mediated PTEN expression. Oncogene. 30:2753–2766.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Lombaerts M, van Wezel T, Philippo K,
Dierssen JW, Zimmerman RM, Oosting J, van Eijk R, Eilers PH, van de
Water B, Cornelisse CJ and Cleton-Jansen AM: E-cadherin
transcriptional downregulation by promoter methylation but not
mutation is related to epithelial-to-mesenchymal transition in
breast cancer cell lines. Br J Cancer. 94:661–671. 2006.PubMed/NCBI
|
|
27
|
Cao ZQ, Shen Z and Huang WY: MicroRNA-802
promotes osteosarcoma cell proliferation by targeting p27. Asian
Pac J Cancer Prev. 14:7081–7084. 2013. View Article : Google Scholar
|
|
28
|
Cheng J, Yang Y, Fang J, Xiao J, Zhu T,
Chen F, Wang P, Li Z, Yang H and Xu Y: Structural insight into
coordinated recognition of trimethylated histone H3 lysine 9
(H3K9me3) by the plant homeodomain (PHD) and tandem tudor domain
(TTD) of UHRF1 (ubiquitin-like, containing PHD and RING finger
domains, 1) protein. J Biol Chem. 288:1329–1339. 2013. View Article : Google Scholar :
|
|
29
|
Sharif J, Muto M, Takebayashi S, Suetake
I, Iwamatsu A, Endo TA, Shinga J, Mizutani-Koseki Y, Toyoda T,
Okamura K, et al: The SRA protein Np95 mediates epigenetic
inheritance by recruiting Dnmt1 to methylated DNA. Nature.
450:908–912. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Puisieux A, Brabletz T and Caramel J:
Oncogenic roles of EMT-inducing transcription factors. Nat Cell
Biol. 16:488–494. 2014. View
Article : Google Scholar : PubMed/NCBI
|
|
31
|
Kalluri R and Weinberg RA: The basics of
epithelial-mesenchymal transition. J Clin Invest. 119:1420–1428.
2009. View
Article : Google Scholar : PubMed/NCBI
|
|
32
|
Xiong H, Hong J, Du W, Lin YW, Ren LL,
Wang YC, Su WY, Wang JL, Cui Y, Wang ZH and Fang JY: Roles of STAT3
and ZEB1 proteins in E-cadherin down-regulation and human
colorectal cancer epithelial-mesenchymal transition. J Biol Chem.
287:5819–5832. 2012. View Article : Google Scholar :
|
|
33
|
Sun XJ, Liu H, Zhang P, Zhang XD, Jiang ZW
and Jiang CC: miR-10b promotes migration and invasion in
nasopharyngeal carcinoma cells. Asian Pac J Cancer Prev.
14:5533–5537. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Wang YP, Wang MZ, Luo YR, Shen Y and Wei
ZX: Lentivirus-mediated shRNA interference targeting SLUG inhibits
lung cancer growth and metastasis. Asian Pac J Cancer Prev.
13:4947–4951. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Kim JK, Estève PO, Jacobsen SE and Pradhan
S: UHRF1 binds G9a and participates in p21 transcriptional
regulation in mammalian cells. Nucleic Acids Res. 37:493–505. 2009.
View Article : Google Scholar :
|
|
36
|
Guan D, Factor D, Liu Y, Wang Z and Kao
HY: The epigenetic regulator UHRF1 promotes ubiquitination-mediated
degradation of the tumor-suppressor protein promyelocytic leukemia
protein. Oncogene. 32:3819–3828. 2013. View Article : Google Scholar :
|
